RETATRUTIDE + CAGRILINTIDE

Overview of Retatrutide and Cagrilintide Research Compounds

This research combination features two distinct peptides, Retatrutide and Cagrilintide, provided in a blended lyophilized format for laboratory investigations. Retatrutide is a synthetic unimolecular peptide known in scientific literature as a triple agonist, interacting with the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon (GCGR) receptors. In biochemical studies, it is often utilized to explore the synergistic effects of multi-receptor activation on metabolic pathways and energy homeostasis.

Cagrilintide is a long-acting acylated analog of the human hormone amylin. As a non-selective amylin receptor agonist (AMRA), it is frequently studied for its role in modulating calcitonin receptors. When combined in a research setting, these two compounds allow scientists to observe the interaction between triple-incretin agonism and amylin-receptor signaling. This blend is specifically formulated for researchers focusing on endocrine signaling, receptor binding affinity, and metabolic chemical reactions in controlled environments.

Specifications

Our commitment to laboratory excellence ensures that every batch meets rigorous quality control standards. The specifications for this research blend include:

• Purity: Greater than 99% as determined by analytical testing.
• Testing: Each lot undergoes third-party HPLC (High-Performance Liquid Chromatography) and MS (Mass Spectrometry) analysis to verify identity and chemical purity.
• Documentation: A Certificate of Analysis (COA) is available for every batch to ensure transparency and data integrity for your research.
• Format: Provided as a sterile, lyophilized (freeze-dried) white powder for enhanced stability.
• Available Sizes: 12.5 mg of Retatrutide combined with 2.5 mg of Cagrilintide per vial.
• Composition: A precise ratio designed for standardized laboratory experimentation.

Handling and Storage

Proper handling and storage are critical to maintaining the chemical integrity of Retatrutide and Cagrilintide. Upon receipt, the lyophilized powder should be stored in a climate-controlled environment. For long-term preservation, it is recommended to store the vials at -20°C. If the product is intended for use within a shorter timeframe (less than three months), refrigeration at 2°C to 8°C is generally sufficient.

The reconstitution process is a standard laboratory procedure. In a controlled environment, the researcher typically introduces a diluent, such as bacteriostatic water or sterile physiological saline, into the vial. During this process, it is vital to avoid vigorous agitation; instead, a gentle swirling motion should be used to dissolve the powder to prevent the denaturation of the peptide chains. Once reconstituted, the solution is significantly less stable than the lyophilized form and should be kept refrigerated and utilized within a specific experimental window, typically not exceeding 28 days for optimal results.

Buy RETATRUTIDE + CAGRILINTIDE Online

Acquiring high-quality research peptides requires a reliable supplier capable of providing consistent purity and documented verification. When you purchase this blend, you are securing a product manufactured to the highest industry standards for laboratory reagents. We understand the importance of timely data collection, which is why we offer fast USA shipping to ensure your laboratory schedule remains uninterrupted.

All orders are processed with discretion and professionalism. We utilize robust packaging materials designed to protect the integrity of the vacuum-sealed vials during transit, minimizing the risk of breakage or exposure to environmental fluctuations. Tracking information is provided for every shipment, allowing researchers to monitor their supply chain from our facility to their laboratory door.

Research Use Only

IMPORTANT: This product is intended solely for in-vitro laboratory research purposes by qualified professionals. It is not a drug, food, cosmetic, or dietary supplement. Retatrutide and Cagrilintide are not for human or veterinary consumption. Any application involving the administration of this compound to humans or animals is strictly prohibited. The purchaser assumes all responsibility for the handling, storage, and application of this chemical in compliance with all local and federal regulations. This material must only be handled by trained individuals who are familiar with the risks associated with research chemicals and laboratory safety protocols.